Rankings
▼
Calendar
EYPT Q4 2025 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$620,000
-94.6% YoY
Gross Profit
$245,000
39.5% margin
Operating Income
-$70M
-11346.0% margin
Net Income
-$68M
-10904.7% margin
EPS (Diluted)
$-0.81
QoQ Revenue Growth
-35.8%
Cash Flow
Operating Cash Flow
-$65M
Free Cash Flow
-$66M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$364M
Total Liabilities
$58M
Stockholders' Equity
$306M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$620,000
$12M
-94.6%
Gross Profit
$245,000
$11M
-97.7%
Operating Income
-$70M
-$45M
-55.5%
Net Income
-$68M
-$41M
-63.3%
← FY 2025
All Quarters